Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry-Reference-Cited by-同舟云学术

Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry

Published:2011-01-20 Issue:6 Volume:152 Page:743-753
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Thörn Ingrid,Forestier Erik,Botling Johan,Thuresson Britt,Wasslavik Carina,Björklund Elisabet,Li Aihong,Lindström-Eriksson Eleonor,Malec Maria,Grönlund Elisabeth,Torikka Kerstin,Heldrup Jesper,Abrahamsson Jonas,Behrendtz Mikael,Söderhäll Stefan,Jacobsson Stefan,Olofsson Tor,Porwit Anna,Lönnerholm Gudmar,Rosenquist Richard,Sundström Christer

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08456.x/fullpdf

Reference46 articles.

1. Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group;Biondi;Leukemia,2000

2. Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia;Bjorklund;Leukemia,2003

3. Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment;Bjorklund;Journal of Pediatric Hematology/oncology,2009

4. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study;Borowitz;Blood,2008

5. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group;Cave;New England Journal of Medicine,1998

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow Cytometry-Based Detection of Minimal/Measurable Residual Disease Predicts Survival Outcomes in Pediatrics, Adolescents, and Young Adults With T-acute Lymphoblastic Leukemia;Cureus;2024-06-05

2. The Use of Flow Cytometry for MRD Detection of B- and T-ALL in Pediatric Patients;Reference Module in Biomedical Sciences;2024

3. Highly sensitive single tube B‐lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy;Cytometry Part B: Clinical Cytometry;2023-03-30

4. Association of Minimal Residual Disease by a Single-Tube 8-Color Flow Cytometric Analysis With Clinical Outcome in Adult B-Cell Acute Lymphoblastic Leukemia;Archives of Pathology & Laboratory Medicine;2022-12-12

5. Wilms tumor 1 gene expression in acute myeloid leukemia: prognostic significance and usefulness in minimal residual disease monitoring—a case–control study;Egyptian Journal of Medical Human Genetics;2022-08-01